Safety and Immunogenicity of a Replication-Defective Adenovirus Type 5 HIV Vaccine in Ad5-Seronegative Persons: A Randomized Clinical Trial (HVTN 054)

BACKGROUND: Individuals without prior immunity to a vaccine vector may be more sensitive to reactions following injection, but may also show optimal immune responses to vaccine antigens. To assess safety and maximal tolerated dose of an adenoviral vaccine vector in volunteers without prior immunity,...

Descripción completa

Detalles Bibliográficos
Autores principales: Peiperl, Laurence, Morgan, Cecilia, Moodie, Zoe, Li, Hongli, Russell, Nina, Graham, Barney S., Tomaras, Georgia D., De Rosa, Stephen C., McElrath, M. Juliana
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2965084/
https://www.ncbi.nlm.nih.gov/pubmed/21048953
http://dx.doi.org/10.1371/journal.pone.0013579

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2965084/
https://www.ncbi.nlm.nih.gov/pubmed/21048953
http://dx.doi.org/10.1371/journal.pone.0013579

Ejemplares similares